Taiwan Pancreas Society, Taiwan Oncology Society, SynCore Biotechnology, Taiwan Bio Industry Organization
Time | Topic |
---|---|
13:00 | 13:30 |
Reception |
13:30 | 13:50 |
Opening RemarksSpeaker:Dr. Shou-Mei Wu, Director General of Taiwan Food and Drug Administration Dr. Li-Tzong Chen, President of Taiwan Oncology Society Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society Dr. Johnsee Lee, Chairman of Taiwan Bio Industry Organization Dr. Muh-Hwan Su, General Manager of SynCore Biotechnology |
Session Moderator: Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society | |
13:50 | 14:20 |
The Experience of mFOLFIRINOX for Patients with Pancreatic CancerSpeaker:Dr. Li Yuan Bai , Director, Division of Hematology and Oncology, China Medical University Hospital, Taiwan |
14:20 | 14:50 |
The Korea Experience of FOLFIRINOX in Pancreatic CancerSpeaker:Dr. Hong Jae Chon, Associate Professor, Medical Oncology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Gyeonggi-Do, Korea |
14:50 | 15:10 |
Coffee Break |
Session Moderator: Dr. Li-Tzong Chen, President of Taiwan Oncology Society | |
15:10 | 15:40 |
The U.S. Experience of FOLFIRINOX in Pancreatic CancerSpeaker:Dr. Philip Agop Philip, Karmanos Cancer Institute, Wayne State University, Leader, GI and Neuroendocrine Oncology, Vice President of Medical Affairs USA |
15:40 | 16:10 |
Retrospective Analysis of FOLFIRINOX Treatment in Advanced Pancreatic Cancer in Out CenterSpeaker:Dr. Zsuzsanna Pápai, Head of the Oncology Department, Medical Center- Hungarian Defense Forces, Budapest, Hungary |
16:10 | 16:40 |
The France Experience of FOLFIRINOX in Pancreatic CancerSpeaker:Dr. Jean-Philippe Metges, Associate Professor & Oncology Physician, Institute of Oncology and Hematology, Brest CHRU, France |
16:40 | 17:10 |
Panel DiscussionSpeaker:Dr. Li Yuan Bai, Director, China Medical University Hospital, Taiwan Dr. Hong Jae Chon, Associate Professor, CHA Bundang Medical Centera, South Korea Dr. Jean-Philippe Metges, Associate Professor, Brest CHRU, France Dr. Philip Agop Philip, Vice President of Medical Affairs USA Dr. Zsuzsanna Pápai, Head of Oncology Department, Hungary Dr. Li-Tzong Chen, President of Taiwan Oncology Dr. Ta-Sen Yeh, President of Taiwan Pancreas Society Dr. Muh-Hwan Su, General Manager, SynCore Biotechnology |
17:10 | 17:20 |
Closing RemarkSpeaker:Dr. Muh-Hwan Su, General Manager, SynCore Biotechnology |
The organizer reserves the right to disposition and reviews the qualifications of registered participants.